Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment

Background and Purpose: The activation of 5-HT(4) receptors with agonists has emerged as a valuable therapeutic strategy to treat Alzheimer’s disease (AD) by enhancing the nonamyloidogenic pathway. Here, the potential therapeutic effects of tegaserod, an effective agent for irritable bowel syndrome,...

Descripción completa

Detalles Bibliográficos
Autores principales: Séguy, Line, Guyon, Léna, Maurel, Manon, Verdié, Pascal, Davis, Audrey, Corvaisier, Sophie, Lisowski, Vincent, Dallemagne, Patrick, Groo, Anne-Claire, Malzert-Fréon, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540544/
https://www.ncbi.nlm.nih.gov/pubmed/34683919
http://dx.doi.org/10.3390/pharmaceutics13101626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540544/
https://www.ncbi.nlm.nih.gov/pubmed/34683919
http://dx.doi.org/10.3390/pharmaceutics13101626

Ejemplares similares